Form 4 Tracker
Moderna, Inc.
MRNA

53 insider filings · Latest: Oct 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 15, 2026Oct 16 8:09 PMStephen HogePresident
Sale
39,145$220.72$8.6M1,636,565(D)

View →

Oct 14, 2026Oct 16 8:09 PMStephen HogePresident
Sale
39,224$213.48$8.4M1,599,258(D)

View →

Oct 15, 2026Oct 15 2:32 PMHoge Stephen
Proposed Sale
39,145$220.72$8.6M—

View →

Oct 14, 2026Oct 14 1:58 PMHoge Stephen
Proposed Sale
39,224$213.48$8.4M—

View →

Sep 15, 2026Sep 16 8:48 PMStephen HogePresident
Sale
40,281$146.07$5.9M1,562,029(D)

View →

Sep 14, 2026Sep 16 8:48 PMStephen HogePresident
Sale
40,294$144.13$5.8M1,525,858(D)

View →

Sep 15, 2026Sep 15 2:46 PMHoge Stephen
Proposed Sale
40,281$146.07$5.9M—

View →

Sep 10, 2026Sep 14 8:25 PMJames M MockChief Financial Officer
Sale
34,836$134.49$4.7M59,375(D)

View →

Sep 14, 2026Sep 14 6:39 PMHoge Stephen
Proposed Sale
40,294$144.13$5.8M—

View →

Sep 10, 2026Sep 10 2:14 PMMock James M
Proposed Sale
34,836$134.49$4.7M—

View →

Sep 1, 2026Sep 3 8:56 PMShannon Thyme KlingerChief Legal Officer
Sale
3,471$139.95$485.8K74,129(D)

View →

Sep 1, 2026Sep 1 3:22 PMKlinger Shannon Thyme
Proposed Sale
3,471$139.95$485.8K—

View →

Aug 5, 2026Aug 7 8:11 PMStephane BancelDirector, Chief Executive Officer
Sale
499,246$57.52$28.7M6,187,791(D)

View →

Aug 5, 2026Aug 5 5:02 PMBancel Stephane
Proposed Sale
499,246$58.00$29.0M—

View →

Jul 15, 2026Jul 16 8:45 PMStephen HogePresident
Sale
53,336$67.60$3.6M1,483,848(D)

View →

Jul 15, 2026Jul 15 2:22 PMHoge Stephen
Proposed Sale
53,336$67.60$3.6M—

View →

Jun 18, 2026Jun 18 7:26 PMSAGAN PAUL
Proposed Sale
25,770$64.57$1.7M—

View →

Jun 15, 2026Jun 17 8:10 PMStephen HogePresident
Sale
53,336$51.37$2.7M1,483,848(D)

View →

Jun 15, 2026Jun 15 3:43 PMHoge Stephen
Proposed Sale
53,336$51.37$2.7M—

View →

Jun 4, 2026Jun 8 8:34 PMShannon Thyme KlingerChief Legal Officer
Sale
3,471$50.00$173.6K67,468(D)

View →

Page 1 of 3

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 6, 2026May 8 9:04 PMSandra HorningDirector
Grant/Award
11,773$48.792,092(D)

View →

May 6, 2026May 8 9:02 PMElizabeth G NabelDirector
Grant/Award
8,371—8,371(D)

View →

May 6, 2026May 8 8:59 PMFrancois NaderDirector
Grant/Award
10,639$48.794,185(D)

View →

May 6, 2026May 8 8:57 PMElizabeth E TallettDirector
Grant/Award
8,371—8,371(D)

View →

May 6, 2026May 8 8:54 PMNoubar AfeyanDirector
Grant/Award
12,908$48.7912,908(D)

View →

Apr 30, 2026May 4 9:39 PMSandra HorningDirector
Option Exercise
16,233—0(D)

View →

Apr 30, 2026May 4 9:36 PMRubenstein David M.Director
Option Exercise
8,116—0(D)

View →

Apr 30, 2026May 4 9:25 PMAbbas HussainDirector
Option Exercise
16,233—0(D)

View →

Apr 30, 2026May 4 8:59 PMElizabeth G NabelDirector
Option Exercise
16,233—0(D)

View →

Apr 30, 2026May 4 8:48 PMFrancois NaderDirector
Option Exercise
12,174—0(D)

View →

Apr 30, 2026May 4 8:44 PMElizabeth E TallettDirector
Option Exercise
4,058—0(D)

View →

Apr 2, 2026Apr 6 8:45 PMJames M MockChief Financial Officer
Option Exercise
1,453—2,906(D)

View →

Mar 5, 2026Mar 6 9:24 PMShannon Thyme KlingerChief Legal Officer
Option Exercise
11,797—129,774(D)

View →

Mar 5, 2026Mar 6 9:21 PMJames M MockChief Financial Officer
Option Exercise
11,797—129,774(D)

View →

Mar 1, 2026Mar 3 9:19 PMStephane BancelDirector, Chief Executive Officer
Grant/Award
250,932$53.57250,932(D)

View →

Mar 1, 2026Mar 3 9:14 PMStephen HogePresident
Grant/Award
290,696$53.57165,230(D)

View →

Feb 27, 2026Mar 3 9:14 PMStephen HogePresident
Option Exercise
39,830—111,393(D)

View →

Mar 2, 2026Mar 3 9:10 PMShannon Thyme KlingerChief Legal Officer
Option Exercise
13,885$30.9641,658(D)

View →

Mar 1, 2026Mar 3 9:10 PMShannon Thyme KlingerChief Legal Officer
Grant/Award
67,828$53.5738,553(D)

View →

Feb 27, 2026Mar 3 9:10 PMShannon Thyme KlingerChief Legal Officer
Option Exercise
9,999—25,992(D)

View →